nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—asthma—chronic obstructive pulmonary disease	0.201	1	CtDrD
Triamcinolone—Corticosteroid Hormone Receptor Agonists—Prednisolone—chronic obstructive pulmonary disease	0.151	0.514	CiPCiCtD
Triamcinolone—Corticosteroid Hormone Receptor Agonists—Prednisone—chronic obstructive pulmonary disease	0.142	0.486	CiPCiCtD
Triamcinolone—Prednisone—chronic obstructive pulmonary disease	0.105	0.506	CrCtD
Triamcinolone—Prednisolone—chronic obstructive pulmonary disease	0.102	0.494	CrCtD
Triamcinolone—SERPINA6—Prednisolone—chronic obstructive pulmonary disease	0.0368	0.385	CbGbCtD
Triamcinolone—NR3C1—Prednisolone—chronic obstructive pulmonary disease	0.0172	0.18	CbGbCtD
Triamcinolone—NR3C1—Prednisone—chronic obstructive pulmonary disease	0.0162	0.17	CbGbCtD
Triamcinolone—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.00711	0.0745	CbGbCtD
Triamcinolone—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0048	0.0504	CbGbCtD
Triamcinolone—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00458	0.048	CbGbCtD
Triamcinolone—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00408	0.0428	CbGbCtD
Triamcinolone—Prednicarbate—Prednisone—chronic obstructive pulmonary disease	0.0034	0.023	CrCrCtD
Triamcinolone—Testolactone—Prednisone—chronic obstructive pulmonary disease	0.0034	0.023	CrCrCtD
Triamcinolone—Beclomethasone—Prednisolone—chronic obstructive pulmonary disease	0.00332	0.0225	CrCrCtD
Triamcinolone—Clocortolone—Prednisolone—chronic obstructive pulmonary disease	0.00332	0.0225	CrCrCtD
Triamcinolone—Testolactone—Prednisolone—chronic obstructive pulmonary disease	0.00332	0.0225	CrCrCtD
Triamcinolone—Prednicarbate—Prednisolone—chronic obstructive pulmonary disease	0.00332	0.0225	CrCrCtD
Triamcinolone—Fluocortolone—Prednisone—chronic obstructive pulmonary disease	0.0033	0.0224	CrCrCtD
Triamcinolone—Fluocortolone—Prednisolone—chronic obstructive pulmonary disease	0.00322	0.0218	CrCrCtD
Triamcinolone—Alclometasone—Prednisone—chronic obstructive pulmonary disease	0.00321	0.0218	CrCrCtD
Triamcinolone—Alclometasone—Prednisolone—chronic obstructive pulmonary disease	0.00313	0.0212	CrCrCtD
Triamcinolone—Fluocinolone Acetonide—Prednisolone—chronic obstructive pulmonary disease	0.00313	0.0212	CrCrCtD
Triamcinolone—Amcinonide—Prednisone—chronic obstructive pulmonary disease	0.00312	0.0212	CrCrCtD
Triamcinolone—Budesonide—Prednisone—chronic obstructive pulmonary disease	0.00312	0.0212	CrCrCtD
Triamcinolone—Amcinonide—Prednisolone—chronic obstructive pulmonary disease	0.00305	0.0207	CrCrCtD
Triamcinolone—Budesonide—Prednisolone—chronic obstructive pulmonary disease	0.00305	0.0207	CrCrCtD
Triamcinolone—Fluoxymesterone—Prednisolone—chronic obstructive pulmonary disease	0.00305	0.0207	CrCrCtD
Triamcinolone—Diflorasone—Prednisone—chronic obstructive pulmonary disease	0.00304	0.0206	CrCrCtD
Triamcinolone—Flunisolide—Prednisone—chronic obstructive pulmonary disease	0.00304	0.0206	CrCrCtD
Triamcinolone—Fludrocortisone—Prednisone—chronic obstructive pulmonary disease	0.00304	0.0206	CrCrCtD
Triamcinolone—Clobetasol propionate—Prednisone—chronic obstructive pulmonary disease	0.00304	0.0206	CrCrCtD
Triamcinolone—Desonide—Prednisone—chronic obstructive pulmonary disease	0.00304	0.0206	CrCrCtD
Triamcinolone—Fludrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.00297	0.0201	CrCrCtD
Triamcinolone—Desonide—Prednisolone—chronic obstructive pulmonary disease	0.00297	0.0201	CrCrCtD
Triamcinolone—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	0.00297	0.0201	CrCrCtD
Triamcinolone—Flunisolide—Prednisolone—chronic obstructive pulmonary disease	0.00297	0.0201	CrCrCtD
Triamcinolone—Clobetasol propionate—Prednisolone—chronic obstructive pulmonary disease	0.00297	0.0201	CrCrCtD
Triamcinolone—Prednisone—Prednisolone—chronic obstructive pulmonary disease	0.00297	0.0201	CrCrCtD
Triamcinolone—Paramethasone—Prednisone—chronic obstructive pulmonary disease	0.00297	0.0201	CrCrCtD
Triamcinolone—Paramethasone—Prednisolone—chronic obstructive pulmonary disease	0.0029	0.0196	CrCrCtD
Triamcinolone—Desoximetasone—Prednisone—chronic obstructive pulmonary disease	0.00289	0.0196	CrCrCtD
Triamcinolone—Fluprednidene Acetate—Prednisone—chronic obstructive pulmonary disease	0.00283	0.0192	CrCrCtD
Triamcinolone—Loteprednol—Prednisone—chronic obstructive pulmonary disease	0.00283	0.0192	CrCrCtD
Triamcinolone—Fluorometholone—Prednisone—chronic obstructive pulmonary disease	0.00283	0.0192	CrCrCtD
Triamcinolone—Mometasone—Prednisone—chronic obstructive pulmonary disease	0.00283	0.0192	CrCrCtD
Triamcinolone—Desoximetasone—Prednisolone—chronic obstructive pulmonary disease	0.00283	0.0192	CrCrCtD
Triamcinolone—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.00276	0.0187	CrCrCtD
Triamcinolone—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.00276	0.0187	CrCrCtD
Triamcinolone—Rimexolone—Prednisone—chronic obstructive pulmonary disease	0.00276	0.0187	CrCrCtD
Triamcinolone—Mometasone—Prednisolone—chronic obstructive pulmonary disease	0.00276	0.0187	CrCrCtD
Triamcinolone—Fluprednidene Acetate—Prednisolone—chronic obstructive pulmonary disease	0.00276	0.0187	CrCrCtD
Triamcinolone—Loteprednol—Prednisolone—chronic obstructive pulmonary disease	0.00276	0.0187	CrCrCtD
Triamcinolone—Fluorometholone—Prednisolone—chronic obstructive pulmonary disease	0.00276	0.0187	CrCrCtD
Triamcinolone—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.0027	0.0183	CrCrCtD
Triamcinolone—Rimexolone—Prednisolone—chronic obstructive pulmonary disease	0.0027	0.0183	CrCrCtD
Triamcinolone—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.0027	0.0183	CrCrCtD
Triamcinolone—Methylprednisolone—Prednisone—chronic obstructive pulmonary disease	0.00264	0.0179	CrCrCtD
Triamcinolone—Prednisolone—Prednisone—chronic obstructive pulmonary disease	0.00259	0.0175	CrCrCtD
Triamcinolone—Methylprednisolone—Prednisolone—chronic obstructive pulmonary disease	0.00258	0.0175	CrCrCtD
Triamcinolone—Hydrocortisone—Prednisone—chronic obstructive pulmonary disease	0.00248	0.0168	CrCrCtD
Triamcinolone—Hydrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.00242	0.0164	CrCrCtD
Triamcinolone—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0024	0.0251	CbGbCtD
Triamcinolone—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00226	0.0237	CbGbCtD
Triamcinolone—BCHE—diaphragm—chronic obstructive pulmonary disease	0.002	0.327	CbGeAlD
Triamcinolone—PTGS2—leg—chronic obstructive pulmonary disease	0.00071	0.116	CbGeAlD
Triamcinolone—SERPINA6—respiratory system—chronic obstructive pulmonary disease	0.000465	0.0758	CbGeAlD
Triamcinolone—SERPINA6—lung—chronic obstructive pulmonary disease	0.000247	0.0403	CbGeAlD
Triamcinolone—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000241	0.0551	CbGpPWpGaD
Triamcinolone—BCHE—respiratory system—chronic obstructive pulmonary disease	0.000229	0.0373	CbGeAlD
Triamcinolone—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.000213	0.0487	CbGpPWpGaD
Triamcinolone—NR3C1—respiratory system—chronic obstructive pulmonary disease	0.000204	0.0332	CbGeAlD
Triamcinolone—PTGS2—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.000201	0.0459	CbGpPWpGaD
Triamcinolone—BCHE—bronchus—chronic obstructive pulmonary disease	0.000188	0.0307	CbGeAlD
Triamcinolone—BCHE—smooth muscle tissue—chronic obstructive pulmonary disease	0.000184	0.03	CbGeAlD
Triamcinolone—NR3C1—connective tissue—chronic obstructive pulmonary disease	0.000179	0.0292	CbGeAlD
Triamcinolone—PTGS2—respiratory system—chronic obstructive pulmonary disease	0.000176	0.0287	CbGeAlD
Triamcinolone—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.000174	0.0398	CbGpPWpGaD
Triamcinolone—BCHE—trachea—chronic obstructive pulmonary disease	0.000169	0.0276	CbGeAlD
Triamcinolone—NR3C1—bronchus—chronic obstructive pulmonary disease	0.000168	0.0273	CbGeAlD
Triamcinolone—NR3C1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000164	0.0267	CbGeAlD
Triamcinolone—PTGS2—connective tissue—chronic obstructive pulmonary disease	0.000155	0.0253	CbGeAlD
Triamcinolone—NR3C1—trachea—chronic obstructive pulmonary disease	0.000151	0.0245	CbGeAlD
Triamcinolone—PTGS2—bronchus—chronic obstructive pulmonary disease	0.000145	0.0237	CbGeAlD
Triamcinolone—PTGS2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000142	0.0231	CbGeAlD
Triamcinolone—PTGS2—trachea—chronic obstructive pulmonary disease	0.00013	0.0212	CbGeAlD
Triamcinolone—BCHE—lung—chronic obstructive pulmonary disease	0.000122	0.0198	CbGeAlD
Triamcinolone—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.000109	0.0248	CbGpPWpGaD
Triamcinolone—NR3C1—lung—chronic obstructive pulmonary disease	0.000108	0.0176	CbGeAlD
Triamcinolone—PTGS2—lung—chronic obstructive pulmonary disease	9.36e-05	0.0153	CbGeAlD
Triamcinolone—BCHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—chronic obstructive pulmonary disease	9.13e-05	0.0209	CbGpPWpGaD
Triamcinolone—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	8.85e-05	0.0202	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—ELANE—chronic obstructive pulmonary disease	8.82e-05	0.0202	CbGpPWpGaD
Triamcinolone—PTGS2—Overview of nanoparticle effects—HMOX1—chronic obstructive pulmonary disease	7.5e-05	0.0171	CbGpPWpGaD
Triamcinolone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—chronic obstructive pulmonary disease	6.81e-05	0.0156	CbGpPWpGaD
Triamcinolone—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	6.78e-05	0.0155	CbGpPWpGaD
Triamcinolone—NR3C1—Transcription factor regulation in adipogenesis—LEP—chronic obstructive pulmonary disease	6.74e-05	0.0154	CbGpPWpGaD
Triamcinolone—Clobetasol propionate—CYP1A1—chronic obstructive pulmonary disease	6.32e-05	0.282	CrCbGaD
Triamcinolone—Clobetasol propionate—CYP1A2—chronic obstructive pulmonary disease	6.1e-05	0.272	CrCbGaD
Triamcinolone—PTGS2—Overview of nanoparticle effects—CRP—chronic obstructive pulmonary disease	5.87e-05	0.0134	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	5.34e-05	0.0122	CbGpPWpGaD
Triamcinolone—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	5.26e-05	0.012	CbGpPWpGaD
Triamcinolone—Dexamethasone—NOS2—chronic obstructive pulmonary disease	5.16e-05	0.23	CrCbGaD
Triamcinolone—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	4.9e-05	0.0112	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	4.88e-05	0.0112	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—MMP12—chronic obstructive pulmonary disease	4.79e-05	0.0109	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—IL13—chronic obstructive pulmonary disease	4.57e-05	0.0105	CbGpPWpGaD
Triamcinolone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	4.57e-05	0.0104	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	4.49e-05	0.0103	CbGpPWpGaD
Triamcinolone—Vasculitis—Prednisone—chronic obstructive pulmonary disease	4.29e-05	0.00095	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	4.29e-05	0.000948	CcSEcCtD
Triamcinolone—Insomnia—Tiotropium—chronic obstructive pulmonary disease	4.26e-05	0.000942	CcSEcCtD
Triamcinolone—Angioedema—Formoterol—chronic obstructive pulmonary disease	4.25e-05	0.000941	CcSEcCtD
Triamcinolone—Angioedema—Arformoterol—chronic obstructive pulmonary disease	4.25e-05	0.000941	CcSEcCtD
Triamcinolone—Back pain—Salbutamol—chronic obstructive pulmonary disease	4.25e-05	0.00094	CcSEcCtD
Triamcinolone—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	4.23e-05	0.000935	CcSEcCtD
Triamcinolone—PTGS2—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	4.2e-05	0.0096	CbGpPWpGaD
Triamcinolone—Malaise—Arformoterol—chronic obstructive pulmonary disease	4.2e-05	0.000928	CcSEcCtD
Triamcinolone—Malaise—Formoterol—chronic obstructive pulmonary disease	4.2e-05	0.000928	CcSEcCtD
Triamcinolone—Hiccups—Prednisone—chronic obstructive pulmonary disease	4.19e-05	0.000927	CcSEcCtD
Triamcinolone—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	4.19e-05	0.000926	CcSEcCtD
Triamcinolone—Angioedema—Montelukast—chronic obstructive pulmonary disease	4.17e-05	0.000921	CcSEcCtD
Triamcinolone—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	4.16e-05	0.0095	CbGpPWpGaD
Triamcinolone—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	4.14e-05	0.000916	CcSEcCtD
Triamcinolone—Affect lability—Prednisolone—chronic obstructive pulmonary disease	4.12e-05	0.000911	CcSEcCtD
Triamcinolone—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	4.08e-05	0.000902	CcSEcCtD
Triamcinolone—Cough—Formoterol—chronic obstructive pulmonary disease	4.06e-05	0.000898	CcSEcCtD
Triamcinolone—Cough—Arformoterol—chronic obstructive pulmonary disease	4.06e-05	0.000898	CcSEcCtD
Triamcinolone—BCHE—Peptide hormone metabolism—ACE—chronic obstructive pulmonary disease	4.05e-05	0.00927	CbGpPWpGaD
Triamcinolone—Hypertension—Arformoterol—chronic obstructive pulmonary disease	4.02e-05	0.000889	CcSEcCtD
Triamcinolone—Hypertension—Formoterol—chronic obstructive pulmonary disease	4.02e-05	0.000889	CcSEcCtD
Triamcinolone—Angioedema—Salbutamol—chronic obstructive pulmonary disease	4.02e-05	0.000888	CcSEcCtD
Triamcinolone—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	4e-05	0.000885	CcSEcCtD
Triamcinolone—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	3.98e-05	0.00088	CcSEcCtD
Triamcinolone—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	3.98e-05	0.0091	CbGpPWpGaD
Triamcinolone—Cough—Montelukast—chronic obstructive pulmonary disease	3.98e-05	0.00088	CcSEcCtD
Triamcinolone—Fluid retention—Prednisone—chronic obstructive pulmonary disease	3.98e-05	0.00088	CcSEcCtD
Triamcinolone—Mood swings—Prednisolone—chronic obstructive pulmonary disease	3.97e-05	0.000877	CcSEcCtD
Triamcinolone—Urticaria—Aminophylline—chronic obstructive pulmonary disease	3.97e-05	0.000877	CcSEcCtD
Triamcinolone—Malaise—Salbutamol—chronic obstructive pulmonary disease	3.96e-05	0.000877	CcSEcCtD
Triamcinolone—Myalgia—Formoterol—chronic obstructive pulmonary disease	3.96e-05	0.000876	CcSEcCtD
Triamcinolone—Myalgia—Arformoterol—chronic obstructive pulmonary disease	3.96e-05	0.000876	CcSEcCtD
Triamcinolone—Convulsion—Montelukast—chronic obstructive pulmonary disease	3.95e-05	0.000874	CcSEcCtD
Triamcinolone—Vertigo—Salbutamol—chronic obstructive pulmonary disease	3.95e-05	0.000873	CcSEcCtD
Triamcinolone—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	3.95e-05	0.000873	CcSEcCtD
Triamcinolone—Syncope—Salbutamol—chronic obstructive pulmonary disease	3.94e-05	0.000872	CcSEcCtD
Triamcinolone—Neuropathy—Prednisone—chronic obstructive pulmonary disease	3.94e-05	0.00087	CcSEcCtD
Triamcinolone—Discomfort—Arformoterol—chronic obstructive pulmonary disease	3.92e-05	0.000866	CcSEcCtD
Triamcinolone—Discomfort—Formoterol—chronic obstructive pulmonary disease	3.92e-05	0.000866	CcSEcCtD
Triamcinolone—Myalgia—Montelukast—chronic obstructive pulmonary disease	3.88e-05	0.000858	CcSEcCtD
Triamcinolone—Dry mouth—Formoterol—chronic obstructive pulmonary disease	3.88e-05	0.000857	CcSEcCtD
Triamcinolone—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	3.88e-05	0.000857	CcSEcCtD
Triamcinolone—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	3.86e-05	0.000854	CcSEcCtD
Triamcinolone—Cough—Salbutamol—chronic obstructive pulmonary disease	3.84e-05	0.000848	CcSEcCtD
Triamcinolone—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	3.82e-05	0.00873	CbGpPWpGaD
Triamcinolone—PTGS2—Overview of nanoparticle effects—CXCL8—chronic obstructive pulmonary disease	3.82e-05	0.00873	CbGpPWpGaD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	3.81e-05	0.00871	CbGpPWpGaD
Triamcinolone—Oedema—Formoterol—chronic obstructive pulmonary disease	3.8e-05	0.00084	CcSEcCtD
Triamcinolone—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	3.8e-05	0.00084	CcSEcCtD
Triamcinolone—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	3.8e-05	0.00084	CcSEcCtD
Triamcinolone—Oedema—Arformoterol—chronic obstructive pulmonary disease	3.8e-05	0.00084	CcSEcCtD
Triamcinolone—Hypertension—Salbutamol—chronic obstructive pulmonary disease	3.8e-05	0.000839	CcSEcCtD
Triamcinolone—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	3.79e-05	0.000838	CcSEcCtD
Triamcinolone—Infection—Arformoterol—chronic obstructive pulmonary disease	3.77e-05	0.000835	CcSEcCtD
Triamcinolone—Infection—Formoterol—chronic obstructive pulmonary disease	3.77e-05	0.000835	CcSEcCtD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—chronic obstructive pulmonary disease	3.77e-05	0.00863	CbGpPWpGaD
Triamcinolone—Myalgia—Salbutamol—chronic obstructive pulmonary disease	3.74e-05	0.000828	CcSEcCtD
Triamcinolone—Urticaria—Tiotropium—chronic obstructive pulmonary disease	3.74e-05	0.000827	CcSEcCtD
Triamcinolone—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	3.73e-05	0.000825	CcSEcCtD
Triamcinolone—Oedema—Montelukast—chronic obstructive pulmonary disease	3.72e-05	0.000823	CcSEcCtD
Triamcinolone—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	3.72e-05	0.000823	CcSEcCtD
Triamcinolone—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	3.71e-05	0.00082	CcSEcCtD
Triamcinolone—Tachycardia—Formoterol—chronic obstructive pulmonary disease	3.71e-05	0.00082	CcSEcCtD
Triamcinolone—Discomfort—Salbutamol—chronic obstructive pulmonary disease	3.7e-05	0.000818	CcSEcCtD
Triamcinolone—Infection—Montelukast—chronic obstructive pulmonary disease	3.7e-05	0.000818	CcSEcCtD
Triamcinolone—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	3.69e-05	0.000816	CcSEcCtD
Triamcinolone—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	3.68e-05	0.000813	CcSEcCtD
Triamcinolone—BCHE—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	3.68e-05	0.0084	CbGpPWpGaD
Triamcinolone—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	3.67e-05	0.0084	CbGpPWpGaD
Triamcinolone—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	3.66e-05	0.000809	CcSEcCtD
Triamcinolone—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	3.64e-05	0.000805	CcSEcCtD
Triamcinolone—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	3.6e-05	0.000796	CcSEcCtD
Triamcinolone—Oedema—Salbutamol—chronic obstructive pulmonary disease	3.59e-05	0.000793	CcSEcCtD
Triamcinolone—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	3.59e-05	0.000793	CcSEcCtD
Triamcinolone—Infection—Salbutamol—chronic obstructive pulmonary disease	3.56e-05	0.000788	CcSEcCtD
Triamcinolone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—chronic obstructive pulmonary disease	3.56e-05	0.00813	CbGpPWpGaD
Triamcinolone—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	3.55e-05	0.000784	CcSEcCtD
Triamcinolone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	3.53e-05	0.000781	CcSEcCtD
Triamcinolone—Shock—Salbutamol—chronic obstructive pulmonary disease	3.53e-05	0.00078	CcSEcCtD
Triamcinolone—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	3.52e-05	0.000779	CcSEcCtD
Triamcinolone—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	3.51e-05	0.000777	CcSEcCtD
Triamcinolone—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	3.5e-05	0.000774	CcSEcCtD
Triamcinolone—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	3.5e-05	0.000773	CcSEcCtD
Triamcinolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—chronic obstructive pulmonary disease	3.49e-05	0.00798	CbGpPWpGaD
Triamcinolone—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	3.47e-05	0.000767	CcSEcCtD
Triamcinolone—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	3.47e-05	0.000767	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	3.46e-05	0.000765	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	3.46e-05	0.000765	CcSEcCtD
Triamcinolone—Insomnia—Formoterol—chronic obstructive pulmonary disease	3.44e-05	0.00076	CcSEcCtD
Triamcinolone—Insomnia—Arformoterol—chronic obstructive pulmonary disease	3.44e-05	0.00076	CcSEcCtD
Triamcinolone—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	3.4e-05	0.000752	CcSEcCtD
Triamcinolone—PTGS2—C-MYB transcription factor network—MPO—chronic obstructive pulmonary disease	3.4e-05	0.00777	CbGpPWpGaD
Triamcinolone—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	3.39e-05	0.00075	CcSEcCtD
Triamcinolone—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	3.39e-05	0.000749	CcSEcCtD
Triamcinolone—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	3.39e-05	0.000749	CcSEcCtD
Triamcinolone—Insomnia—Montelukast—chronic obstructive pulmonary disease	3.37e-05	0.000744	CcSEcCtD
Triamcinolone—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	3.35e-05	0.000742	CcSEcCtD
Triamcinolone—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	3.34e-05	0.00074	CcSEcCtD
Triamcinolone—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	3.34e-05	0.00074	CcSEcCtD
Triamcinolone—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	3.34e-05	0.000739	CcSEcCtD
Triamcinolone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	3.33e-05	0.000737	CcSEcCtD
Triamcinolone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	3.32e-05	0.00758	CbGpPWpGaD
Triamcinolone—Injury—Prednisone—chronic obstructive pulmonary disease	3.31e-05	0.000732	CcSEcCtD
Triamcinolone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	3.3e-05	0.00073	CcSEcCtD
Triamcinolone—Weight increased—Prednisolone—chronic obstructive pulmonary disease	3.29e-05	0.000728	CcSEcCtD
Triamcinolone—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—chronic obstructive pulmonary disease	3.28e-05	0.00751	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—EDN1—chronic obstructive pulmonary disease	3.28e-05	0.00751	CbGpPWpGaD
Triamcinolone—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	3.28e-05	0.000724	CcSEcCtD
Triamcinolone—Fatigue—Arformoterol—chronic obstructive pulmonary disease	3.28e-05	0.000724	CcSEcCtD
Triamcinolone—Fatigue—Formoterol—chronic obstructive pulmonary disease	3.28e-05	0.000724	CcSEcCtD
Triamcinolone—PTGS2—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	3.28e-05	0.00749	CbGpPWpGaD
Triamcinolone—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	3.27e-05	0.000723	CcSEcCtD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	3.26e-05	0.00746	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	3.26e-05	0.00744	CbGpPWpGaD
Triamcinolone—Pain—Formoterol—chronic obstructive pulmonary disease	3.25e-05	0.000718	CcSEcCtD
Triamcinolone—Pain—Arformoterol—chronic obstructive pulmonary disease	3.25e-05	0.000718	CcSEcCtD
Triamcinolone—NR3C1—AP-1 transcription factor network—IL10—chronic obstructive pulmonary disease	3.25e-05	0.00742	CbGpPWpGaD
Triamcinolone—Insomnia—Salbutamol—chronic obstructive pulmonary disease	3.24e-05	0.000718	CcSEcCtD
Triamcinolone—Increased appetite—Prednisone—chronic obstructive pulmonary disease	3.24e-05	0.000716	CcSEcCtD
Triamcinolone—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	3.22e-05	0.000712	CcSEcCtD
Triamcinolone—Fatigue—Montelukast—chronic obstructive pulmonary disease	3.21e-05	0.000709	CcSEcCtD
Triamcinolone—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	3.2e-05	0.000707	CcSEcCtD
Triamcinolone—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	3.18e-05	0.00728	CbGpPWpGaD
Triamcinolone—Pain—Montelukast—chronic obstructive pulmonary disease	3.18e-05	0.000704	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	3.18e-05	0.000703	CcSEcCtD
Triamcinolone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	3.17e-05	0.000702	CcSEcCtD
Triamcinolone—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	3.16e-05	0.000699	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	3.16e-05	0.000699	CcSEcCtD
Triamcinolone—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	3.16e-05	0.000698	CcSEcCtD
Triamcinolone—Purpura—Prednisone—chronic obstructive pulmonary disease	3.16e-05	0.000698	CcSEcCtD
Triamcinolone—Rash—Aminophylline—chronic obstructive pulmonary disease	3.15e-05	0.000696	CcSEcCtD
Triamcinolone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	3.14e-05	0.000695	CcSEcCtD
Triamcinolone—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	3.14e-05	0.000693	CcSEcCtD
Triamcinolone—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	3.13e-05	0.000692	CcSEcCtD
Triamcinolone—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	3.13e-05	0.000692	CcSEcCtD
Triamcinolone—Headache—Aminophylline—chronic obstructive pulmonary disease	3.13e-05	0.000692	CcSEcCtD
Triamcinolone—NR3C1—Transcription factor regulation in adipogenesis—TNF—chronic obstructive pulmonary disease	3.12e-05	0.00713	CbGpPWpGaD
Triamcinolone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	3.11e-05	0.000688	CcSEcCtD
Triamcinolone—PTGS2—S1P1 pathway—VEGFA—chronic obstructive pulmonary disease	3.1e-05	0.00709	CbGpPWpGaD
Triamcinolone—Fatigue—Salbutamol—chronic obstructive pulmonary disease	3.09e-05	0.000684	CcSEcCtD
Triamcinolone—Pain—Salbutamol—chronic obstructive pulmonary disease	3.07e-05	0.000678	CcSEcCtD
Triamcinolone—PTGS2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	3.05e-05	0.00698	CbGpPWpGaD
Triamcinolone—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	3.04e-05	0.000673	CcSEcCtD
Triamcinolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	3.03e-05	0.00693	CbGpPWpGaD
Triamcinolone—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	3.02e-05	0.0069	CbGpPWpGaD
Triamcinolone—Urticaria—Arformoterol—chronic obstructive pulmonary disease	3.02e-05	0.000667	CcSEcCtD
Triamcinolone—Urticaria—Formoterol—chronic obstructive pulmonary disease	3.02e-05	0.000667	CcSEcCtD
Triamcinolone—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	3e-05	0.000664	CcSEcCtD
Triamcinolone—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	3e-05	0.000664	CcSEcCtD
Triamcinolone—BCHE—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	3e-05	0.00685	CbGpPWpGaD
Triamcinolone—Affect lability—Prednisone—chronic obstructive pulmonary disease	2.99e-05	0.000662	CcSEcCtD
Triamcinolone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	2.99e-05	0.000662	CcSEcCtD
Triamcinolone—Rash—Tiotropium—chronic obstructive pulmonary disease	2.97e-05	0.000656	CcSEcCtD
Triamcinolone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	2.97e-05	0.000656	CcSEcCtD
Triamcinolone—Nausea—Aminophylline—chronic obstructive pulmonary disease	2.97e-05	0.000656	CcSEcCtD
Triamcinolone—Urticaria—Montelukast—chronic obstructive pulmonary disease	2.96e-05	0.000654	CcSEcCtD
Triamcinolone—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	2.96e-05	0.000654	CcSEcCtD
Triamcinolone—Headache—Tiotropium—chronic obstructive pulmonary disease	2.95e-05	0.000652	CcSEcCtD
Triamcinolone—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	2.95e-05	0.000652	CcSEcCtD
Triamcinolone—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	2.94e-05	0.000651	CcSEcCtD
Triamcinolone—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	2.91e-05	0.000644	CcSEcCtD
Triamcinolone—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	2.9e-05	0.00064	CcSEcCtD
Triamcinolone—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	2.89e-05	0.00064	CcSEcCtD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	2.89e-05	0.0066	CbGpPWpGaD
Triamcinolone—Mood swings—Prednisone—chronic obstructive pulmonary disease	2.88e-05	0.000637	CcSEcCtD
Triamcinolone—Urticaria—Salbutamol—chronic obstructive pulmonary disease	2.85e-05	0.00063	CcSEcCtD
Triamcinolone—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	2.84e-05	0.000627	CcSEcCtD
Triamcinolone—BCHE—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	2.82e-05	0.00644	CbGpPWpGaD
Triamcinolone—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	2.8e-05	0.000619	CcSEcCtD
Triamcinolone—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	2.8e-05	0.000619	CcSEcCtD
Triamcinolone—Nausea—Tiotropium—chronic obstructive pulmonary disease	2.8e-05	0.000618	CcSEcCtD
Triamcinolone—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	2.78e-05	0.00634	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—MMP1—chronic obstructive pulmonary disease	2.76e-05	0.00631	CbGpPWpGaD
Triamcinolone—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	2.74e-05	0.000606	CcSEcCtD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	2.73e-05	0.00625	CbGpPWpGaD
Triamcinolone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	2.73e-05	0.000603	CcSEcCtD
Triamcinolone—Asthenia—Formoterol—chronic obstructive pulmonary disease	2.73e-05	0.000603	CcSEcCtD
Triamcinolone—NR3C1—AP-1 transcription factor network—PLAU—chronic obstructive pulmonary disease	2.71e-05	0.00619	CbGpPWpGaD
Triamcinolone—Pruritus—Formoterol—chronic obstructive pulmonary disease	2.69e-05	0.000594	CcSEcCtD
Triamcinolone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	2.69e-05	0.000594	CcSEcCtD
Triamcinolone—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	2.68e-05	0.000593	CcSEcCtD
Triamcinolone—Asthenia—Montelukast—chronic obstructive pulmonary disease	2.67e-05	0.00059	CcSEcCtD
Triamcinolone—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	2.67e-05	0.0061	CbGpPWpGaD
Triamcinolone—PTGS2—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	2.66e-05	0.00608	CbGpPWpGaD
Triamcinolone—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	2.65e-05	0.000585	CcSEcCtD
Triamcinolone—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	2.64e-05	0.000584	CcSEcCtD
Triamcinolone—Pruritus—Montelukast—chronic obstructive pulmonary disease	2.63e-05	0.000582	CcSEcCtD
Triamcinolone—NR3C1—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	2.62e-05	0.00599	CbGpPWpGaD
Triamcinolone—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	2.59e-05	0.000572	CcSEcCtD
Triamcinolone—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	2.58e-05	0.00057	CcSEcCtD
Triamcinolone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	2.57e-05	0.000569	CcSEcCtD
Triamcinolone—Sweating increased—Prednisone—chronic obstructive pulmonary disease	2.56e-05	0.000566	CcSEcCtD
Triamcinolone—NR3C1—Circadian Clock—SERPINE1—chronic obstructive pulmonary disease	2.54e-05	0.00581	CbGpPWpGaD
Triamcinolone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	2.54e-05	0.000561	CcSEcCtD
Triamcinolone—Erythema—Prednisolone—chronic obstructive pulmonary disease	2.52e-05	0.000558	CcSEcCtD
Triamcinolone—BCHE—Peptide hormone metabolism—LEP—chronic obstructive pulmonary disease	2.52e-05	0.00576	CbGpPWpGaD
Triamcinolone—NR3C1—Transcription factor regulation in adipogenesis—IL6—chronic obstructive pulmonary disease	2.52e-05	0.00575	CbGpPWpGaD
Triamcinolone—Dizziness—Formoterol—chronic obstructive pulmonary disease	2.51e-05	0.000556	CcSEcCtD
Triamcinolone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	2.51e-05	0.000556	CcSEcCtD
Triamcinolone—Prednisone—ALB—chronic obstructive pulmonary disease	2.51e-05	0.112	CrCbGaD
Triamcinolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	2.5e-05	0.00571	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	2.47e-05	0.00564	CbGpPWpGaD
Triamcinolone—Dizziness—Montelukast—chronic obstructive pulmonary disease	2.46e-05	0.000544	CcSEcCtD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—chronic obstructive pulmonary disease	2.43e-05	0.00556	CbGpPWpGaD
Triamcinolone—Vomiting—Formoterol—chronic obstructive pulmonary disease	2.42e-05	0.000534	CcSEcCtD
Triamcinolone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	2.42e-05	0.000534	CcSEcCtD
Triamcinolone—Rash—Arformoterol—chronic obstructive pulmonary disease	2.4e-05	0.00053	CcSEcCtD
Triamcinolone—Rash—Formoterol—chronic obstructive pulmonary disease	2.4e-05	0.00053	CcSEcCtD
Triamcinolone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	2.39e-05	0.000529	CcSEcCtD
Triamcinolone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	2.39e-05	0.000529	CcSEcCtD
Triamcinolone—Weight increased—Prednisone—chronic obstructive pulmonary disease	2.39e-05	0.000529	CcSEcCtD
Triamcinolone—Headache—Formoterol—chronic obstructive pulmonary disease	2.38e-05	0.000526	CcSEcCtD
Triamcinolone—Headache—Arformoterol—chronic obstructive pulmonary disease	2.38e-05	0.000526	CcSEcCtD
Triamcinolone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	2.37e-05	0.000525	CcSEcCtD
Triamcinolone—Dexamethasone—CYP1A1—chronic obstructive pulmonary disease	2.37e-05	0.105	CrCbGaD
Triamcinolone—Vomiting—Montelukast—chronic obstructive pulmonary disease	2.37e-05	0.000523	CcSEcCtD
Triamcinolone—Rash—Montelukast—chronic obstructive pulmonary disease	2.35e-05	0.000519	CcSEcCtD
Triamcinolone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	2.34e-05	0.000518	CcSEcCtD
Triamcinolone—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	2.34e-05	0.000517	CcSEcCtD
Triamcinolone—Headache—Montelukast—chronic obstructive pulmonary disease	2.33e-05	0.000516	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	2.31e-05	0.000511	CcSEcCtD
Triamcinolone—Angioedema—Prednisolone—chronic obstructive pulmonary disease	2.3e-05	0.000509	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	2.3e-05	0.000508	CcSEcCtD
Triamcinolone—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	2.3e-05	0.000508	CcSEcCtD
Triamcinolone—BCHE—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	2.3e-05	0.00525	CbGpPWpGaD
Triamcinolone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	2.28e-05	0.000504	CcSEcCtD
Triamcinolone—Malaise—Prednisolone—chronic obstructive pulmonary disease	2.27e-05	0.000503	CcSEcCtD
Triamcinolone—Vertigo—Prednisolone—chronic obstructive pulmonary disease	2.27e-05	0.000501	CcSEcCtD
Triamcinolone—Rash—Salbutamol—chronic obstructive pulmonary disease	2.26e-05	0.0005	CcSEcCtD
Triamcinolone—Syncope—Prednisolone—chronic obstructive pulmonary disease	2.26e-05	0.0005	CcSEcCtD
Triamcinolone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	2.26e-05	0.0005	CcSEcCtD
Triamcinolone—Nausea—Arformoterol—chronic obstructive pulmonary disease	2.26e-05	0.000499	CcSEcCtD
Triamcinolone—Nausea—Formoterol—chronic obstructive pulmonary disease	2.26e-05	0.000499	CcSEcCtD
Triamcinolone—Headache—Salbutamol—chronic obstructive pulmonary disease	2.25e-05	0.000497	CcSEcCtD
Triamcinolone—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	2.22e-05	0.00049	CcSEcCtD
Triamcinolone—Nausea—Montelukast—chronic obstructive pulmonary disease	2.21e-05	0.000489	CcSEcCtD
Triamcinolone—Convulsion—Prednisolone—chronic obstructive pulmonary disease	2.18e-05	0.000483	CcSEcCtD
Triamcinolone—Hypertension—Prednisolone—chronic obstructive pulmonary disease	2.18e-05	0.000481	CcSEcCtD
Triamcinolone—PTGS2—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	2.14e-05	0.0049	CbGpPWpGaD
Triamcinolone—Bradycardia—Prednisone—chronic obstructive pulmonary disease	2.14e-05	0.000474	CcSEcCtD
Triamcinolone—Nausea—Salbutamol—chronic obstructive pulmonary disease	2.13e-05	0.000471	CcSEcCtD
Triamcinolone—PTGS2—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	2.13e-05	0.00486	CbGpPWpGaD
Triamcinolone—Discomfort—Prednisolone—chronic obstructive pulmonary disease	2.12e-05	0.000469	CcSEcCtD
Triamcinolone—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	2.12e-05	0.000468	CcSEcCtD
Triamcinolone—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	2.1e-05	0.000465	CcSEcCtD
Triamcinolone—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	2.06e-05	0.000455	CcSEcCtD
Triamcinolone—Oedema—Prednisolone—chronic obstructive pulmonary disease	2.06e-05	0.000455	CcSEcCtD
Triamcinolone—Shock—Prednisolone—chronic obstructive pulmonary disease	2.02e-05	0.000448	CcSEcCtD
Triamcinolone—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	2.01e-05	0.000444	CcSEcCtD
Triamcinolone—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	1.99e-05	0.00044	CcSEcCtD
Triamcinolone—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	1.96e-05	0.00448	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	1.95e-05	0.00446	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	1.92e-05	0.00439	CbGpPWpGaD
Triamcinolone—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	1.88e-05	0.000416	CcSEcCtD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	1.87e-05	0.00426	CbGpPWpGaD
Triamcinolone—Insomnia—Prednisolone—chronic obstructive pulmonary disease	1.86e-05	0.000412	CcSEcCtD
Triamcinolone—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	1.85e-05	0.000409	CcSEcCtD
Triamcinolone—Erythema—Prednisone—chronic obstructive pulmonary disease	1.83e-05	0.000405	CcSEcCtD
Triamcinolone—NR3C1—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	1.78e-05	0.00406	CbGpPWpGaD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—chronic obstructive pulmonary disease	1.76e-05	0.00402	CbGpPWpGaD
Triamcinolone—Pain—Prednisolone—chronic obstructive pulmonary disease	1.76e-05	0.000389	CcSEcCtD
Triamcinolone—PTGS2—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	1.72e-05	0.00394	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	1.71e-05	0.00391	CbGpPWpGaD
Triamcinolone—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	1.7e-05	0.000376	CcSEcCtD
Triamcinolone—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	1.7e-05	0.000375	CcSEcCtD
Triamcinolone—Angioedema—Prednisone—chronic obstructive pulmonary disease	1.67e-05	0.00037	CcSEcCtD
Triamcinolone—BCHE—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	1.66e-05	0.0038	CbGpPWpGaD
Triamcinolone—Malaise—Prednisone—chronic obstructive pulmonary disease	1.65e-05	0.000365	CcSEcCtD
Triamcinolone—Vertigo—Prednisone—chronic obstructive pulmonary disease	1.65e-05	0.000364	CcSEcCtD
Triamcinolone—Syncope—Prednisone—chronic obstructive pulmonary disease	1.64e-05	0.000363	CcSEcCtD
Triamcinolone—Urticaria—Prednisolone—chronic obstructive pulmonary disease	1.63e-05	0.000361	CcSEcCtD
Triamcinolone—NR3C1—Adipogenesis—LEP—chronic obstructive pulmonary disease	1.63e-05	0.00372	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	1.62e-05	0.00371	CbGpPWpGaD
Triamcinolone—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	1.61e-05	0.000356	CcSEcCtD
Triamcinolone—NR3C1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	1.61e-05	0.00367	CbGpPWpGaD
Triamcinolone—Convulsion—Prednisone—chronic obstructive pulmonary disease	1.59e-05	0.000351	CcSEcCtD
Triamcinolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	1.59e-05	0.00363	CbGpPWpGaD
Triamcinolone—Hypertension—Prednisone—chronic obstructive pulmonary disease	1.58e-05	0.00035	CcSEcCtD
Triamcinolone—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	1.57e-05	0.00358	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—chronic obstructive pulmonary disease	1.56e-05	0.00358	CbGpPWpGaD
Triamcinolone—Myalgia—Prednisone—chronic obstructive pulmonary disease	1.56e-05	0.000345	CcSEcCtD
Triamcinolone—Discomfort—Prednisone—chronic obstructive pulmonary disease	1.54e-05	0.000341	CcSEcCtD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	1.53e-05	0.00349	CbGpPWpGaD
Triamcinolone—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	1.52e-05	0.000335	CcSEcCtD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	1.51e-05	0.00346	CbGpPWpGaD
Triamcinolone—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	1.5e-05	0.000331	CcSEcCtD
Triamcinolone—Oedema—Prednisone—chronic obstructive pulmonary disease	1.5e-05	0.000331	CcSEcCtD
Triamcinolone—Infection—Prednisone—chronic obstructive pulmonary disease	1.49e-05	0.000328	CcSEcCtD
Triamcinolone—Shock—Prednisone—chronic obstructive pulmonary disease	1.47e-05	0.000325	CcSEcCtD
Triamcinolone—Tachycardia—Prednisone—chronic obstructive pulmonary disease	1.46e-05	0.000323	CcSEcCtD
Triamcinolone—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	1.45e-05	0.00032	CcSEcCtD
Triamcinolone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	1.44e-05	0.00329	CbGpPWpGaD
Triamcinolone—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	1.43e-05	0.00326	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	1.38e-05	0.00314	CbGpPWpGaD
Triamcinolone—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	1.36e-05	0.000301	CcSEcCtD
Triamcinolone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	1.36e-05	0.000301	CcSEcCtD
Triamcinolone—NR3C1—Endoderm Differentiation—TGFB1—chronic obstructive pulmonary disease	1.35e-05	0.0031	CbGpPWpGaD
Triamcinolone—Insomnia—Prednisone—chronic obstructive pulmonary disease	1.35e-05	0.000299	CcSEcCtD
Triamcinolone—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	1.34e-05	0.000297	CcSEcCtD
Triamcinolone—PTGS2—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	1.33e-05	0.00305	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—APIP—chronic obstructive pulmonary disease	1.33e-05	0.00304	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	1.32e-05	0.00302	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	1.32e-05	0.00302	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	1.32e-05	0.00302	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	1.32e-05	0.00302	CbGpPWpGaD
Triamcinolone—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	1.32e-05	0.000291	CcSEcCtD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	1.31e-05	0.00299	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	1.31e-05	0.00299	CbGpPWpGaD
Triamcinolone—Rash—Prednisolone—chronic obstructive pulmonary disease	1.3e-05	0.000287	CcSEcCtD
Triamcinolone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	1.3e-05	0.000287	CcSEcCtD
Triamcinolone—Fatigue—Prednisone—chronic obstructive pulmonary disease	1.29e-05	0.000285	CcSEcCtD
Triamcinolone—Headache—Prednisolone—chronic obstructive pulmonary disease	1.29e-05	0.000285	CcSEcCtD
Triamcinolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	1.29e-05	0.00294	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	1.28e-05	0.00292	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	1.24e-05	0.00284	CbGpPWpGaD
Triamcinolone—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	1.23e-05	0.000272	CcSEcCtD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic obstructive pulmonary disease	1.23e-05	0.0028	CbGpPWpGaD
Triamcinolone—Nausea—Prednisolone—chronic obstructive pulmonary disease	1.22e-05	0.00027	CcSEcCtD
Triamcinolone—Urticaria—Prednisone—chronic obstructive pulmonary disease	1.19e-05	0.000263	CcSEcCtD
Triamcinolone—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	1.18e-05	0.000261	CcSEcCtD
Triamcinolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	1.15e-05	0.00263	CbGpPWpGaD
Triamcinolone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	1.14e-05	0.0026	CbGpPWpGaD
Triamcinolone—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	1.1e-05	0.000244	CcSEcCtD
Triamcinolone—NR3C1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	1.09e-05	0.00249	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	1.07e-05	0.00246	CbGpPWpGaD
Triamcinolone—Asthenia—Prednisone—chronic obstructive pulmonary disease	1.07e-05	0.000237	CcSEcCtD
Triamcinolone—Pruritus—Prednisone—chronic obstructive pulmonary disease	1.06e-05	0.000234	CcSEcCtD
Triamcinolone—NR3C1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	1.02e-05	0.00234	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	9.97e-06	0.00228	CbGpPWpGaD
Triamcinolone—Dizziness—Prednisone—chronic obstructive pulmonary disease	9.89e-06	0.000219	CcSEcCtD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—TP53—chronic obstructive pulmonary disease	9.6e-06	0.00219	CbGpPWpGaD
Triamcinolone—Vomiting—Prednisone—chronic obstructive pulmonary disease	9.51e-06	0.00021	CcSEcCtD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	9.47e-06	0.00216	CbGpPWpGaD
Triamcinolone—Rash—Prednisone—chronic obstructive pulmonary disease	9.43e-06	0.000208	CcSEcCtD
Triamcinolone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	9.42e-06	0.000208	CcSEcCtD
Triamcinolone—Headache—Prednisone—chronic obstructive pulmonary disease	9.37e-06	0.000207	CcSEcCtD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	9.35e-06	0.00214	CbGpPWpGaD
Triamcinolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.34e-06	0.00214	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—APIP—chronic obstructive pulmonary disease	9.14e-06	0.00209	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	8.97e-06	0.00205	CbGpPWpGaD
Triamcinolone—Nausea—Prednisone—chronic obstructive pulmonary disease	8.88e-06	0.000196	CcSEcCtD
Triamcinolone—PTGS2—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	8.86e-06	0.00202	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.8e-06	0.00201	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—IL6—chronic obstructive pulmonary disease	8.79e-06	0.00201	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	8.72e-06	0.00199	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GC—chronic obstructive pulmonary disease	8.56e-06	0.00196	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	8.5e-06	0.00194	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.22e-06	0.00188	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.12e-06	0.00186	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	8.06e-06	0.00184	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	8.01e-06	0.00183	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.96e-06	0.00182	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	7.8e-06	0.00178	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	7.65e-06	0.00175	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	7.59e-06	0.00174	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—TNF—chronic obstructive pulmonary disease	7.53e-06	0.00172	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	6.87e-06	0.00157	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.83e-06	0.00156	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.74e-06	0.00154	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	6.6e-06	0.00151	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.52e-06	0.00149	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	6.51e-06	0.00149	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	6.48e-06	0.00148	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.34e-06	0.00145	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	6.29e-06	0.00144	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	6.17e-06	0.00141	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—IL6—chronic obstructive pulmonary disease	6.08e-06	0.00139	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.06e-06	0.00138	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.01e-06	0.00137	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	5.89e-06	0.00135	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.7e-06	0.0013	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.62e-06	0.00128	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.48e-06	0.00125	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	5.44e-06	0.00124	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	5.25e-06	0.0012	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.23e-06	0.0012	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.16e-06	0.00118	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	4.98e-06	0.00114	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.96e-06	0.00113	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—CTGF—chronic obstructive pulmonary disease	4.93e-06	0.00113	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	4.91e-06	0.00112	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.89e-06	0.00112	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.89e-06	0.00112	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	4.75e-06	0.00109	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.68e-06	0.00107	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	4.66e-06	0.00107	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GCLC—chronic obstructive pulmonary disease	4.62e-06	0.00106	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	4.59e-06	0.00105	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	4.49e-06	0.00103	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.4e-06	0.00101	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.36e-06	0.000997	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.31e-06	0.000985	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CTGF—chronic obstructive pulmonary disease	4.22e-06	0.000964	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	4.2e-06	0.000959	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.99e-06	0.000913	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.89e-06	0.000888	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.7e-06	0.000845	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.24e-06	0.000741	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	3.23e-06	0.000738	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.22e-06	0.000736	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.2e-06	0.000731	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	3.18e-06	0.000727	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	3.16e-06	0.000722	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—KL—chronic obstructive pulmonary disease	3e-06	0.000686	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.98e-06	0.000681	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.97e-06	0.000678	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.9e-06	0.000663	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.82e-06	0.000645	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.67e-06	0.000611	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.64e-06	0.000604	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.57e-06	0.000588	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.39e-06	0.000547	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	2.25e-06	0.000514	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	2.25e-06	0.000513	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.23e-06	0.00051	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.2e-06	0.000503	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.05e-06	0.000469	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.94e-06	0.000444	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ALB—chronic obstructive pulmonary disease	1.92e-06	0.000439	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	1.88e-06	0.000429	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—NOS3—chronic obstructive pulmonary disease	1.84e-06	0.00042	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	1.58e-06	0.000361	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	1.51e-06	0.000345	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.41e-06	0.000321	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.39e-06	0.000318	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	1.32e-06	0.000302	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.27e-06	0.00029	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.26e-06	0.000289	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.17e-06	0.000267	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	9.98e-07	0.000228	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	9.78e-07	0.000224	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.74e-07	0.000223	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.61e-07	0.00022	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.95e-07	0.000205	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.49e-07	0.000194	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	7.52e-07	0.000172	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.77e-07	0.000132	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.52e-07	0.000126	CbGpPWpGaD
